The 5th International Conference on HIV Pathogenesis, Treatment and Prevention took place in Cape Town, South Africa from July 19-22, 2009.
Relay’s Co-Editor-in-Chief Dr. Harold Dion was there and reports some of the highlights from the meeting.

Can fewer drugs work as well in resistant HIV?

A study presented by the team at Montreal’s Clinique médicale l’Actuel demonstrated that it might be possible to reduce the number of different medications needed by people who have developed resistance to triple therapy.

Epidemiology

South Africa has the greatest number of people living with HIV of anywhere in the world.

New treatments

A phase 2 trial of a new integrase inhibitor (S/GSK1439572) showed remarkable activity at a dose of 50 mg taken as monotherapy once a day.